Dynavax Technologies
DVAX
#4991
Rank
NZ$3.09 B
Marketcap
NZ$26.32
Share price
0.00%
Change (1 day)
11.54%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : NZ$1.10 Billion

According to Dynavax Technologies 's latest financial reports the company has NZ$1.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$1.26 B7.83%
2023-12-31NZ$1.17 B19.35%
2022-12-31NZ$0.98 B23.04%
2021-12-31NZ$0.79 B249.45%
2020-12-31NZ$0.22 B1.98%
2019-12-31NZ$0.22 B3.38%
2018-12-31NZ$0.21 B-19.68%
2017-12-31NZ$0.27 B129.84%
2016-12-31NZ$0.11 B-58.98%
2015-12-31NZ$0.28 B83.06%
2014-12-31NZ$0.15 B-32.07%
2013-12-31NZ$0.23 B51.51%
2012-12-31NZ$0.15 B4.17%
2011-12-31NZ$0.14 B56.13%
2010-12-31NZ$93.52 M84.99%
2009-12-31NZ$50.55 M-57.16%
2008-12-31NZ$0.11 B2.42%
2007-12-31NZ$0.11 B11.44%
2006-12-31NZ$0.10 B-5.92%
2005-12-31NZ$0.10 B19.09%
2004-12-31NZ$92.27 M106.15%
2003-12-31NZ$44.76 M-20.35%
2002-12-31NZ$56.19 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
NZ$23.08 B 1,998.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.50 B 1,309.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$6.47 B 489.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.32 B 1,383.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$24.73 B 2,148.33%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$9.71 B 782.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$7.22 B 556.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
NZ$5.87 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$6.03 B 448.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel